[go: up one dir, main page]

AU2001280604A1 - Compositions comprising icariside i and anhydroicaritin and methods for making the same - Google Patents

Compositions comprising icariside i and anhydroicaritin and methods for making the same

Info

Publication number
AU2001280604A1
AU2001280604A1 AU2001280604A AU8060401A AU2001280604A1 AU 2001280604 A1 AU2001280604 A1 AU 2001280604A1 AU 2001280604 A AU2001280604 A AU 2001280604A AU 8060401 A AU8060401 A AU 8060401A AU 2001280604 A1 AU2001280604 A1 AU 2001280604A1
Authority
AU
Australia
Prior art keywords
anhydroicaritin
icariside
compositions
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280604A
Inventor
David T. Bailey
Rod Lenoble
Coralee G. Mannila
Rebecca L. Nichols
Steven L. Richheimer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hauser Inc
Original Assignee
Hauser Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hauser Inc filed Critical Hauser Inc
Publication of AU2001280604A1 publication Critical patent/AU2001280604A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001280604A 2000-08-15 2001-07-19 Compositions comprising icariside i and anhydroicaritin and methods for making the same Abandoned AU2001280604A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09638367 2000-08-15
US09/638,367 US6399579B1 (en) 2000-08-15 2000-08-15 Compositions comprising icariside I and anhydroicaritin and methods for making the same
PCT/US2001/022700 WO2002013842A1 (en) 2000-08-15 2001-07-19 Compositions comprising icariside i and anhydroicaritin and methods for making the same

Publications (1)

Publication Number Publication Date
AU2001280604A1 true AU2001280604A1 (en) 2002-02-25

Family

ID=24559750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280604A Abandoned AU2001280604A1 (en) 2000-08-15 2001-07-19 Compositions comprising icariside i and anhydroicaritin and methods for making the same

Country Status (3)

Country Link
US (1) US6399579B1 (en)
AU (1) AU2001280604A1 (en)
WO (1) WO2002013842A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770436B2 (en) * 2000-09-22 2004-02-19 Unilever Plc Use of prenylated flavones
US6476203B1 (en) * 2002-03-14 2002-11-05 Xinxian Zhao Safe pharmaceutical composition for treating and preventing infertility and increasing immune function
ITMI20020994A1 (en) * 2002-05-10 2003-11-10 Indena Spa USEFUL FORMULATIONS IN THE TREATMENT OF MALE AND FEMALE IMPOTENCE
US20040253326A1 (en) * 2003-02-25 2004-12-16 Mesko Charles A. Composition for increasing levels of hormones and a method for preparation of said composition
WO2007031140A2 (en) * 2005-07-15 2007-03-22 Dr. Willmar Schwabe Gmbh & Co. Kg Extracts from epimedium species method for production and use thereof
KR100803577B1 (en) * 2005-11-30 2008-02-15 (주)아모레퍼시픽 Cosmetic composition containing a hydrolyzate of icarin
CN101113157A (en) * 2006-07-28 2008-01-30 上海特化医药科技有限公司 Prenyl flavone derivatives, preparation method and use thereof
KR20080025960A (en) * 2006-09-19 2008-03-24 (주)아모레퍼시픽 Process for preparing Icaricide I and whitening composition containing the same
JP5265556B2 (en) 2006-10-25 2013-08-14 シェノゲン・ファーマ・グループ・リミテッド Compounds and methods for treating estrogen receptor related diseases
CN101302548B (en) * 2007-05-09 2011-04-13 北京珅奥基医药科技有限公司 Preparation of icaritin
WO2009129372A1 (en) * 2008-04-18 2009-10-22 Shenogen Pharma Group Ltd. Compounds and methods for treating estrogen receptor-related diseases
US8530433B2 (en) * 2008-06-13 2013-09-10 Bjo-Biomed Ltd Use of icariside II in manufacture of products for preventing or treating male or female sexual dysfunction
CN101607976B (en) * 2008-06-19 2013-09-04 贵州省中国科学院天然产物化学重点实验室 Method for preparing icariin
CN101891782B (en) * 2010-06-23 2016-08-24 吉林大学 The separation method of icariside I monomer in Korean epimedium leaves
CN101899077A (en) * 2010-06-23 2010-12-01 吉林大学 Extraction method and application of icariside I in Epimedium Korean leaves
CN103159723A (en) * 2011-12-19 2013-06-19 中国科学院大连化学物理研究所 Preparation method for pure anhydroicaritin
DE102013017165A1 (en) * 2013-10-16 2015-04-16 Eberhard Karls Universität Tübingen Medizinische Fakultät Composition for immunomodulation
WO2015058664A1 (en) 2013-10-21 2015-04-30 鲁南制药集团股份有限公司 Use of icariin in preparing medicine for preventing or treating decrease in blood cells
CN108486196A (en) * 2015-05-20 2018-09-04 佛山市金骏康健康科技有限公司 A kind of preparation method of icariside I or epimedroside C
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN108558812A (en) * 2018-03-26 2018-09-21 北京珅奥基医药科技有限公司 A kind of method that acidolysis prepares icariine
CN109342585A (en) * 2018-10-10 2019-02-15 泓博元生命科技（深圳）有限公司 The determination method of Herba Epimedii
CN110180669B (en) * 2019-06-25 2024-02-27 重庆化工职业学院 Method for extracting epimedium herb by superfine grinding device
CN115175676B (en) 2020-03-10 2025-03-04 鲁南制药集团股份有限公司 Medical Uses of Epimedin
CN111643538A (en) * 2020-07-20 2020-09-11 成都农业科技职业学院 Epimedium root extract and its prepn and use
CN112063672A (en) * 2020-09-23 2020-12-11 浙大宁波理工学院 A process for preparing icariin II by exoglucanase
CN114214379A (en) * 2021-12-27 2022-03-22 安徽九鑫药业有限公司 A process for converting and extracting icariin by coupling flavonidase
CN114605483B (en) * 2022-04-06 2024-01-30 贵州汇腾科技有限公司 Preparation process of icariside I
CN114605424A (en) * 2022-04-06 2022-06-10 贵州汇腾科技有限公司 Preparation process of cycloicaritin

Also Published As

Publication number Publication date
US6399579B1 (en) 2002-06-04
WO2002013842A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2778801A (en) Antisense compositions and methods
AUPQ419099A0 (en) Novel compositions and methods
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2001219651A1 (en) Mulch composition and method
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2349399A (en) R-lansoprazole compositions and methods
AUPQ875700A0 (en) Combination compositions
AU2002231295A1 (en) Developed seed and methods for making the same
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001241098A1 (en) Composition
AU2001233932A1 (en) Method and composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001275201A1 (en) Acne-treating composition
AUPQ644900A0 (en) Preserving compositions
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2001287852A1 (en) Composition
AU2001235764A1 (en) Compositions
AU2001266290A1 (en) Thermochromic composition
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2002239775A1 (en) Chemical-library composition and method
AUPR099200A0 (en) New formulation
AU2001287732A1 (en) Copolycarbonate-based composition